• Policy & Insight

Less red tape and lower costs: How the UK-EU political reset can support cancer research progress worldwide

As we launch our new report, “Nothing should stand in the way”, we reflect on how the UK and EU could be more ambitious, grasping opportunities for closer scientific cooperation to promote health and wealth across the continent and beyond As we launch our new report, “Nothing should stand in the way”, we reflect on how the UK and EU could be more ambitious, grasping opportunities for closer scientific cooperation to promote health and wealth across the continent and beyond

22 April 2025

• Policy & Insight
• Health & Medicine

Detecting prostate cancer: why we need more research

We set out why we believe there are currently no easy solutions to prostate cancer early diagnosis, and what we’re doing at Cancer Research UK to change that. We set out why we believe there are currently no easy solutions to prostate cancer early diagnosis, and what we’re doing at Cancer Research UK to change that.

14 April 2025

• Policy & Insight

A key milestone passed: The Tobacco and Vapes Bill completes Report Stage and Third Reading Stage in the House of Commons

After hours of debate in the House of Commons, MPs have voted in favour of the Tobacco and Vapes Bill during its Third Reading. After hours of debate in the House of Commons, MPs have voted in favour of the Tobacco and Vapes Bill during its Third Reading.

27 March 2025

• Policy & Insight

Early warnings, better outcomes: Getting the infrastructure right to unlock data for cancer detection

To get the most out of data-driven programmes we need to see some changes in the UK’s health data infrastructure. Here we explore what those changes need to be, and how programmes like CD3 can align with government’s priorities.  To get the most out of data-driven programmes we need to see some changes in the UK’s health data infrastructure. Here we explore what those changes need to be, and how programmes like CD3 can align with government’s priorities. 

19 March 2025

• Policy & Insight

Research clusters: How the Industrial Strategy can enhance the UK life sciences ecosystems

Today we've published a new report outlining our expertise in building research clusters and how they can boost the UK R&D landscape Today we've published a new report outlining our expertise in building research clusters and how they can boost the UK R&D landscape

12 March 2025

• Policy & Insight

The road to a smokefree UK: MLAs in Northern Ireland vote in favour of Tobacco and Vapes Bill

Today marks an important and exciting day for our Smokefree UK campaign, with Members of the Legislative Assembly voting in favour of the Tobacco and Vapes Bill at the Northern Ireland Legislative Consent Motion. Today marks an important and exciting day for our Smokefree UK campaign, with Members of the Legislative Assembly voting in favour of the Tobacco and Vapes Bill at the Northern Ireland Legislative Consent Motion.

10 February 2025

• Policy & Insight

Mission-based funding: A Cancer Research UK approach to lung cancer research

We look back on how more than 10-years of mission-based funding has transformed the UK lung cancer research ecosystem and what our new mission focused government can learn from our approach. We look back on how more than 10-years of mission-based funding has transformed the UK lung cancer research ecosystem and what our new mission focused government can learn from our approach.

13 January 2025

• Policy & Insight

2024 in review - 7 significant steps forward for cancer policy

It's been a busy year for the policy team at Cancer Research UK! From campaigning for tobacco control to working internationally to beat cervical cancer, here are seven policy highlights from 2024. It's been a busy year for the policy team at Cancer Research UK! From campaigning for tobacco control to working internationally to beat cervical cancer, here are seven policy highlights from 2024.

27 December 2024

• Policy & Insight

What role can NHS scientists play in delivering the genomic revolution?

Alice Hilborn, policy advisor at Cancer Research UK, sits down with David Wells, chief executive at the Institute of Biomedical Science (IBMS), to understand the views of the IBMS on the future of genomic medicine, and the role healthcare scientists could play. Alice Hilborn, policy advisor at Cancer Research UK, sits down with David Wells, chief executive at the Institute of Biomedical Science (IBMS), to understand the views of the IBMS on the future of genomic medicine, and the role healthcare scientists could play.

10 December 2024

• Policy & Insight

Bringing our stories to Westminster – how our Campaigns Ambassadors are championing a smokefree UK

Last week more than 75 of our Campaigns Ambassadors gathered for Parliament Day to show their support for the Tobacco and Vapes Bill. Last week more than 75 of our Campaigns Ambassadors gathered for Parliament Day to show their support for the Tobacco and Vapes Bill.

3 December 2024